title: Reactive granulomatous dermatitis presenting as subcutaneous nodules and cords in a patient with advanced myelodysplastic syndrome.
authors.affiliation: Department of Dermatology, Yale School of Medicine, 333 Cedar St, LCI 501, PO Box 208059, New Haven, CT, USA.
authors.forename: Jason
authors.initials: J
authors.lastname: Weed
authors.affiliation: Department of Dermatology, Yale School of Medicine, 333 Cedar St, LCI 501, PO Box 208059, New Haven, CT, USA.
authors.forename: Christine
authors.initials: C
authors.lastname: Ko
authors.affiliation: Department of Hematology, Yale School of Medicine, 333 Cedar Street WWW-403, P.O. Box 208021, New Haven, CT, 06520-8021, USA.
authors.forename: Maximilian
authors.initials: M
authors.lastname: Stahl
authors.affiliation: Department of Hematology, Yale School of Medicine, 333 Cedar Street WWW-403, P.O. Box 208021, New Haven, CT, 06520-8021, USA.
authors.forename: Melissa
authors.initials: M
authors.lastname: Much
authors.affiliation: Department of Hematology, Yale School of Medicine, 333 Cedar Street WWW-403, P.O. Box 208021, New Haven, CT, 06520-8021, USA.
authors.forename: David
authors.initials: D
authors.lastname: Witt
authors.affiliation: Department of Hematology, Yale School of Medicine, 333 Cedar Street WWW-403, P.O. Box 208021, New Haven, CT, 06520-8021, USA.
authors.forename: Amer M
authors.initials: AM
authors.lastname: Zeidan
authors.affiliation: Department of Dermatology, Yale School of Medicine, 333 Cedar St, LCI 501, PO Box 208059, New Haven, CT, USA. Jonathan.Leventhal@yale.edu.
authors.forename: Jonathan
authors.identifier: 0000-0002-3757-8477
authors.initials: J
authors.lastname: Leventhal
mesh_terms: D000368:Aged; D001803:Blood Transfusion; D015897:Comorbidity; D017809:Fatal Outcome; D005260:Female; D006099:Granuloma / Q000209:etiology* / Q000473:pathology; D006644:Histiocytes / Q000473:pathology; D006801:Humans; D000077269:Lenalidomide; D009102:Multiple Organ Failure / Q000209:etiology; D009190:Myelodysplastic Syndromes / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D009504:Neutrophils / Q000473:pathology; D010257:Paraneoplastic Syndromes / Q000209:etiology* / Q000473:pathology; D011241:Prednisone / Q000627:therapeutic use; D013792:Thalidomide / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D013792:Thalidomide; D000077269:Lenalidomide; D011241:Prednisone